IOVANCE BIOTHERAPEUTICS, INC. (IOVA) › Net IncomeIOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2008: -$58.7K2009: -$15.8K2010: -$1.61M2011: -$25.69M2012: -$3.31M2013: -$25.38M2014: -$12.04M2015: -$27.66M2016: -$52.89M2017: -$92.06M2018: -$123.58M2019: -$197.56M2020: -$259.58M2021: -$342.25M2022: -$395.89M2023: -$444.04M2024: -$372.18M2025: -$390.98M-$390.98M2008Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$390.98M-5.1%2024-$372.18M+16.2%2023-$444.04M-12.2%2022-$395.89M-15.7%2021-$342.25M-31.8%2020-$259.58M-31.4%2019-$197.56M-59.9%2018-$123.58M-34.2%2017-$92.06M-74.1%2016-$52.89M-91.2%2015-$27.66M-129.8%2014-$12.04M+52.6%2013-$25.38M-667.4%2012-$3.31M+87.1%2011-$25.69M-1497.9%2010-$1.61M-10095.2%2009-$15.8K+73.1%2008-$58.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share